Ani pharmaceuticals reports third quarter 2020 results

Baudette, minn.--(business wire)--ani pharmaceuticals, inc. (“ani” or the “company”) (nasdaq: anip) today announced business highlights and financial results for the three and nine months ended september 30, 2020. business and recent highlights: company's supplemental new drug application (“snda”) for lead product, cortrophin gel, re-filing on track; driving commercial and operational readiness for a successful launch; welcomed nikhil lalwani as president and ceo, on september 8, 2020; and broa
ANIP Ratings Summary
ANIP Quant Ranking